Cytokinetics Inc (CYTK)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Robert I. Blum |
| Employees: | 250 |
| Web site: | cytokinetics.com |
|
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
(650) 624-3000
| |
| Date | Ratio |
|---|---|
| 2013-06-25 | 1:6 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Cytokinetics, Incorporated focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure.
Please log in first to see chart